HERCULES: A prostate cancer (PC) sequencing panel for parallel analysis of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs).

Authors

null

Daniel Bsteh

Division of Medical Oncology, Department of Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA

Daniel Bsteh , Jonathan Buckley , Dejerianne Ostrow , Jean-Hugues Parmentier , Smruthi Maganti , Scott Mitchell , Seth Sadis , Jeff Smith , Jingwei Ni , Xinzhan Peng , Ana Aparicio , Brian Francis Chapin , David I. Quinn , David James McConkey , Tanya B. Dorff , Ian Thompson Jr., Vinay Duddalwar , Timothy Junius Triche , Amir Goldkorn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Epidemiology/Outcomes

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5036)

DOI

10.1200/JCO.2023.41.16_suppl.5036

Abstract #

5036

Poster Bd #

130

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Genitourinary Cancers Symposium

Fragmentomics of cell-free DNA from targeted panels in genitourinary malignancies.

Fragmentomics of cell-free DNA from targeted panels in genitourinary malignancies.

First Author: Amy K Taylor

First Author: Qiang Zhang

Poster

2023 ASCO Genitourinary Cancers Symposium

Genomic alterations in patients with prostate cancer with liver metastases.

Genomic alterations in patients with prostate cancer with liver metastases.

First Author: Crystal Casado

Poster

2023 ASCO Genitourinary Cancers Symposium

Evaluation of the aggressive variant prostate cancer molecular profile (AVPCm) in CLIA environments.

Evaluation of the aggressive variant prostate cancer molecular profile (AVPCm) in CLIA environments.

First Author: Paul Vincent Viscuse